Comment on 'Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease'
Clin Exp Dermatol
.
2023 Jul 21;48(8):930-931.
doi: 10.1093/ced/llad118.
Authors
Fabrizio Martora
1
,
Teresa Battista
1
,
Luca Potestio
1
,
Massimiliano Scalvenzi
1
,
Paola Nappa
1
,
Matteo Megna
1
Affiliation
1
Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
PMID:
36994825
DOI:
10.1093/ced/llad118
No abstract available
Publication types
Letter
Comment
MeSH terms
Crohn Disease* / complications
Crohn Disease* / drug therapy
Epidermolysis Bullosa Acquisita* / drug therapy
Humans
Ustekinumab / adverse effects
Substances
Ustekinumab